Cargando…
Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report
BACKGROUND: Macrophage activation syndrome is classified as a secondary form of hemophagocytic lymphohistiocytosis. It is a hyperinflammatory complication observed to be comorbid with a variety of autoimmune diseases, including adult-onset Still’s disease and systemic juvenile idiopathic arthritis....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495443/ https://www.ncbi.nlm.nih.gov/pubmed/34620236 http://dx.doi.org/10.1186/s13256-021-03072-1 |
_version_ | 1784579554085437440 |
---|---|
author | Gouda, Wesam Alsaqabi, Faisal Moshrif, Abdelhfeez Abbas, Awad S. Abdel-Aziz, Tarek M. Islam, Md Asiful |
author_facet | Gouda, Wesam Alsaqabi, Faisal Moshrif, Abdelhfeez Abbas, Awad S. Abdel-Aziz, Tarek M. Islam, Md Asiful |
author_sort | Gouda, Wesam |
collection | PubMed |
description | BACKGROUND: Macrophage activation syndrome is classified as a secondary form of hemophagocytic lymphohistiocytosis. It is a hyperinflammatory complication observed to be comorbid with a variety of autoimmune diseases, including adult-onset Still’s disease and systemic juvenile idiopathic arthritis. Macrophage activation syndrome is less commonly detected in adult patients with systemic lupus erythematosus, which, if untreated, can be fatal, though determining the optimum treatment strategy is still a challenge. CASE PRESENTATION: Herein, we report a case of macrophage activation syndrome in a 33-year-old Egyptian female as an unusual complication of a systemic lupus erythematosus flare in adult patients. Our patient was initially treated with a combination of intravenous methylprednisolone pulse therapy and intravenous immunoglobulin therapy, which was followed by a course of oral prednisolone and oral cyclosporine with little response. Switching from oral prednisone to intravenous dexamethasone sodium phosphate showed a more favorable clinical and biochemical response. CONCLUSION: Macrophage activation syndrome is less commonly detected in adult patients with systemic lupus erythematosus. Our case demonstrates that dexamethasone sodium phosphate can be a successful alternative treatment for patients with systemic lupus erythematosus complicated by macrophage activation syndrome in whom the response to pulse methylprednisolone was inadequate to manage their illness, proving to be remarkably effective in a relatively short time frame. |
format | Online Article Text |
id | pubmed-8495443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84954432021-10-07 Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report Gouda, Wesam Alsaqabi, Faisal Moshrif, Abdelhfeez Abbas, Awad S. Abdel-Aziz, Tarek M. Islam, Md Asiful J Med Case Rep Case Report BACKGROUND: Macrophage activation syndrome is classified as a secondary form of hemophagocytic lymphohistiocytosis. It is a hyperinflammatory complication observed to be comorbid with a variety of autoimmune diseases, including adult-onset Still’s disease and systemic juvenile idiopathic arthritis. Macrophage activation syndrome is less commonly detected in adult patients with systemic lupus erythematosus, which, if untreated, can be fatal, though determining the optimum treatment strategy is still a challenge. CASE PRESENTATION: Herein, we report a case of macrophage activation syndrome in a 33-year-old Egyptian female as an unusual complication of a systemic lupus erythematosus flare in adult patients. Our patient was initially treated with a combination of intravenous methylprednisolone pulse therapy and intravenous immunoglobulin therapy, which was followed by a course of oral prednisolone and oral cyclosporine with little response. Switching from oral prednisone to intravenous dexamethasone sodium phosphate showed a more favorable clinical and biochemical response. CONCLUSION: Macrophage activation syndrome is less commonly detected in adult patients with systemic lupus erythematosus. Our case demonstrates that dexamethasone sodium phosphate can be a successful alternative treatment for patients with systemic lupus erythematosus complicated by macrophage activation syndrome in whom the response to pulse methylprednisolone was inadequate to manage their illness, proving to be remarkably effective in a relatively short time frame. BioMed Central 2021-10-07 /pmc/articles/PMC8495443/ /pubmed/34620236 http://dx.doi.org/10.1186/s13256-021-03072-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Gouda, Wesam Alsaqabi, Faisal Moshrif, Abdelhfeez Abbas, Awad S. Abdel-Aziz, Tarek M. Islam, Md Asiful Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report |
title | Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report |
title_full | Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report |
title_fullStr | Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report |
title_full_unstemmed | Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report |
title_short | Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report |
title_sort | macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495443/ https://www.ncbi.nlm.nih.gov/pubmed/34620236 http://dx.doi.org/10.1186/s13256-021-03072-1 |
work_keys_str_mv | AT goudawesam macrophageactivationsyndrometriggeredbysystemiclupuserythematosusflaresuccessfultreatmentwithacombinationofdexamethasonesodiumphosphateintravenousimmunoglobulinandcyclosporineacasereport AT alsaqabifaisal macrophageactivationsyndrometriggeredbysystemiclupuserythematosusflaresuccessfultreatmentwithacombinationofdexamethasonesodiumphosphateintravenousimmunoglobulinandcyclosporineacasereport AT moshrifabdelhfeez macrophageactivationsyndrometriggeredbysystemiclupuserythematosusflaresuccessfultreatmentwithacombinationofdexamethasonesodiumphosphateintravenousimmunoglobulinandcyclosporineacasereport AT abbasawads macrophageactivationsyndrometriggeredbysystemiclupuserythematosusflaresuccessfultreatmentwithacombinationofdexamethasonesodiumphosphateintravenousimmunoglobulinandcyclosporineacasereport AT abdelaziztarekm macrophageactivationsyndrometriggeredbysystemiclupuserythematosusflaresuccessfultreatmentwithacombinationofdexamethasonesodiumphosphateintravenousimmunoglobulinandcyclosporineacasereport AT islammdasiful macrophageactivationsyndrometriggeredbysystemiclupuserythematosusflaresuccessfultreatmentwithacombinationofdexamethasonesodiumphosphateintravenousimmunoglobulinandcyclosporineacasereport |